Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis
Clinical trial NCT02872142 · COMPLETED
Trial details
- NCT number
- NCT02872142
- Sponsor
- Grifols Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-29
- Primary completion
- 2019-08-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.